Symbols

Symbols

BCDA

BCDA

BioCardia Q3 2025 Earnings Call Highlights: CardiAMP Updates and Regulatory Milestones

Wednesday Nov 12, 2025

BioCardia Reports Q3 Loss of $1.48mln, Beating Estimates

Monday Nov 10, 2025

BioCardia Enrolls First Patient in Phase 3 CardiAMP HF II Trial.

Wednesday Nov 05, 2025

BioCardia to Host Q3 2025 Corporate Update and Financial Results Conference Call on November 12, 2025

Thursday Oct 30, 2025

BioCardia Announces First Patient Enrollment in Phase 3 CardiAMP HF II Trial.

Monday Sep 29, 2025

BridgeBio's 15min chart triggers KDJ Death Cross, bearish Marubozu formation observed.

CorWave Announces Promising Results from First-In-Human Implant at HFSA Meeting

Tuesday Sep 23, 2025

Bio Green Med Pref: Bollinger Bands expanding downward, KDJ Death Cross triggered.

Super X Ai's 15min chart signals Bollinger Bands Narrowing, KDJ Death Cross, Bearish Marubozu.

Insider Buying Report: SAVA and BCDA

BioCardia Directors Buy 480,000 Shares at $1.25/Share on 2025-09-19

Monday Sep 22, 2025

Biocardia: HC Wainwright Raises Buy PT to $25 from $25

BioCardia Seeks Approval in Japan for Cell Therapy for Ischemic Heart Failure

BioCardia receives positive preliminary consultation from Japan's PMDA on Heart Failure Trial.

Thursday Sep 18, 2025

BioCardia reports positive results from CardiAMP Cell Therapy trial.

Thursday Sep 04, 2025

BioCardia's President to Present at H. C. Wainwright 27th Annual Global Investment Conference.

BioCardia CEO Peter Altman to Present at H.C. Wainwright Annual Global Investment Conference in New York City

Monday Sep 01, 2025

BioCardia’s Q2 Earnings Call Highlights Cautious Optimism Amid Regulatory Progress and Partnership Discussions

Monday Aug 25, 2025

BioCardia CEO Altman Peter Buys 700 Shares at $1.83/Share on 2023-08-22.

Wednesday Aug 13, 2025

BioCardia, CART-Tech Partner on Heart3D Fusion Imaging for Interventional Cardiology